Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Zenotech Laboratories Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹46.16 |
|---|---|
| Day's Range | ₹45.48 - ₹46.80 |
| Open | ₹46.80 |
| 52 Week Range | ₹33.55 - ₹64.00 |
| Volume | 7,406 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 3.42 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 0.00 |
| TTM EPS (₹) | -2.05 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | -181.10 |
| Face Value (₹) | 10.00 |
| ROCE(%) | -9.32 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 121.31 | 430.47 |
| Expenses | N/A | N/A |
| PBT | 31.86 | 106.92 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 12.3 | 56.13 |
About Zenotech Laboratories Ltd.
| Founded | 1989 |
|---|
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,65,506.97 | 1,960.05 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,90,744.48 | 7,295.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,68,249.69 | 4,951.55 | 3,376.40 - 3,376.40 |
| Apollo Hospitals Enterprise Ltd. | 1,27,984.16 | 8,953.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,16,212.59 | 1,441.95 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,13,101.97 | 1,163.35 | 835.50 - 835.50 |
| Lupin Ltd. | 1,12,911.87 | 2,502.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,06,266.86 | 1,097.95 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,04,508.63 | 2,592.00 | 1,909.70 - 1,909.70 |
| Dr. Reddy's Laboratories Ltd. | 1,03,979.74 | 1,234.20 | 1,148.40 - 1,148.40 |
No Records Found
Latest News
Zenotech Laboratories informs about newspaper publication
Zenotech Laboratories informs about outcome of board meeting
Further to its communication dated April 23, 2026, Zenotech Laboratories has informed that the Meeting of the Board of Directors of the Company was held today, April 29, 2026, which commenced at 11:30 am and concluded at 3:50 pm IST. The Board has, approved the Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026, pursuant to Regulation 33 of SEBI (Listing and Disclosure Requirements) Regulations, 2015 (Listing Regulations), along with the Auditor’s Report thereon and Declaration under Regulation 33(3)(d) of Listing Regulations are annexed.
The above information is a part of company’s filings submitted to BSE.
Zenotech Laboratories inform about board meeting
Zenotech Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, April 29, 2026, to consider and approve Audited Standalone Financial Results of the Company for the quarter and financial year ended March 31, 2026. Further to its communication dated March 26, 2026, the Trading Window has been closed from April 01, 2026 and will remain closed until May 01, 2026, after 48 hours of the declaration of financial results.
The above information is a part of company’s filings submitted to BSE.
Gujarat Themis Biosyn informs about disclosure
Gujarat Inject Kerala informs about outcome of board meeting
Pursuant to Regulations 30, 33 and other applicable regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Gujarat Inject Kerala has informed that the Board of Directors of the Company at its meeting held today Wednesday, 15th July, 2026 has discussed, approved, and taken on record the following matter: 1. Approved Un-Audited Financial Results of the Company for the First Quarter ended on 30th June, 2026; and 2. took on record ‘Limited Review Report’ thereon issued by S Mandawat & Co., Statutory Auditors of the Company. A copy of the approved Un-Audited Financial Results along with Limited Review Report are enclosed. The meeting commenced at 09:00 am and concluded at 09:45 am at the Registered Office of the Company.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Zenotech Laboratories Ltd. is ₹46.16 as of 2026-07-15.
The market capitalisation of Zenotech Laboratories Ltd. is ₹287.15 as of 2026-07-14.
The 1-year return of Zenotech Laboratories Ltd. is -14.83% as of 2025-07-14.
The P/E ratio of Zenotech Laboratories Ltd. is 56.45 as of 2026-07-15.
The 52-week high and low of Zenotech Laboratories Ltd. are ₹64.00 and ₹33.55, respectively, as of 2026-07-15.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
